跳至主要内容
临床试验/IRCT20190303042905N2
IRCT20190303042905N2已完成2 期

The Effects of butyrate supplementation on the expression levels of PGC-1a, PPARa and UCP1 genes, serum level of GLP-1, metabolic parameters, and anthropometric indices in obese individuals on a weight loss diet: A Triple- Blind, Randomized, Placebo- Controlled Clinical Trial.

Ahvaz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Body mass index (BMI) between 30-40
  • Both of genders female and male
  • Age between 18-60 years old

排除标准

  • Unwillingness to participate in the study
  • Kidney diseases, liver failure, heart failure, rheumatic diseases, diabetes, malignancies, and gastrointestinal diseases
  • Consumption of any product or supplement containing probiotics, prebiotics and antibiotics in the last 1 month
  • Taking vitamin, fiber, omega-3, antioxidant supplements during the 3 weeks before and during the study
  • Taking weight-loss drugs and following a weight loss diet for the past six months
  • History of bariatric surgery
  • Pregnancy, lactation, menopause

研究者

相似试验